Basic Information
| LncRNA/CircRNA Name | LINC01125 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Microarray, Western blot |
| Sample | breast tissue, cell line MCF-10A |
| Expression Pattern | up-regulated |
| Function Description | We used lncRNA microarray to investigate the potential genes regulated by LXR-623. As a result, LINC01125 was found to be significantly upregulated in the cells treated with LXR-623. |
| Pubmed ID | 30867411 |
| Year | 2019 |
| Title | The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. |
External Links
| Links for LINC01125 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |